top of page
ART BioScience
Therapeutics for Duchenne Muscular Dystrophy
Company Name | Updating Date | Neurotech Category | Market Category | Target Market | Technologies | Company Founded Year | Company Number of Employees |
|---|---|---|---|---|---|---|---|
ART BioScience | NeuroPharmacology | NeuroBioTechnology | Biotechnology & Biopharmaceutical | Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis) | Biochemical: pharmacological drugs (Developing drugs) | 01/01/2015 | "1-10" |
ART BioScience is a company based on novel messenger RNA technologies for the development of therapeutics that may potentially change the course of Duchenne Muscular Dystrophy.
ART BioScience was founded by Mr. Oren Ozeri and Mr. Alon Hazan, fathers of two children diagnosed with Duchenne Muscular Dystrophy.
bottom of page